![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Effect of Baseline NS5A Polymorphisms on Virologic Response to the All-Oral Combination of Daclatasvir + Sofosbuvir ± Ribavirin in Patients With Chronic HCV Infection
|
|
|
Reported by Jules Levin
The International Liver Congress™ 2014
49th Annual Meeting of the European Association for the Study of the Liver
London, UK, April 9-13, 2014
McPhee F,1 Zhou N,1 Yang X,1 Hernandez D,1 Chiarella J,2 Kozal M2
1Bristol Myers Squibb, Wallingford, CT, USA
2Yale University School of Medicine, New Haven, CT, USA
![CROI1.gif](../images/041114/041114-13/CROI1.gif)
![CROI2.gif](../images/041114/041114-13/CROI2.gif)
![CROI3.gif](../images/041114/041114-13/CROI3.gif)
![CROI4.gif](../images/041114/041114-13/CROI4.gif)
![CROI5.gif](../images/041114/041114-13/CROI5.gif)
![CROI6.gif](../images/041114/041114-13/CROI6.gif)
![CROI7.gif](../images/041114/041114-13/CROI7.gif)
![CROI8.gif](../images/041114/041114-13/CROI8.gif)
![CROI9.gif](../images/041114/041114-13/CROI9.gif)
![CROI10.gif](../images/041114/041114-13/CROI10.gif)
![CROI11.gif](../images/041114/041114-13/CROI11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|